Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review
J Yang, R Xu, C Wang, J Qiu, B Ren… - Cancer …, 2021 - Wiley Online Library
Pancreatic cancer is a highly malignant digestive system tumor with a poor prognosis. Most
pancreatic cancer patients are diagnosed at an advanced stage or even metastasis due to …
pancreatic cancer patients are diagnosed at an advanced stage or even metastasis due to …
Pancreatic ductal adenocarcinoma: current and evolving therapies
A Adamska, A Domenichini, M Falasca - International journal of molecular …, 2017 - mdpi.com
Pancreatic ductal adenocarcinoma (PDAC), which constitutes 90% of pancreatic cancers, is
the fourth leading cause of cancer-related deaths in the world. Due to the broad …
the fourth leading cause of cancer-related deaths in the world. Due to the broad …
Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes
Membrane bound vesicles, including microvesicles and exosomes, are secreted by both
normal and cancerous cells into the extracellular space and in blood circulation. These …
normal and cancerous cells into the extracellular space and in blood circulation. These …
MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls
Purpose: Our goal was to identify circulating micro RNA (miRNA) levels that could
distinguish patients with low-stage pancreatic cancer from healthy and disease controls …
distinguish patients with low-stage pancreatic cancer from healthy and disease controls …
[HTML][HTML] Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway
D Ren, B Lin, X Zhang, Y Peng, Z Ye, Y Ma, Y Liang… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Emerging studies indicated that cancer stem cells represent a subpopulation of cells within
the tumor that is responsible for chemotherapeutic resistance. However, the underlying …
the tumor that is responsible for chemotherapeutic resistance. However, the underlying …
Early diagnosis of pancreatic cancer: challenges and new developments
Pancreatic cancer is a lethal malignancy with its incidence almost equivalent to mortality.
The complex pathophysiology, absence of early diagnostic and prognostic markers and …
The complex pathophysiology, absence of early diagnostic and prognostic markers and …
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
M Abue, M Yokoyama, R Shibuya… - International …, 2014 - spandidos-publications.com
Several recent studies have revealed that microRNAs (miRNAs) have a role in
carcinogenesis and cancer development, and that it is stably detectable in plasma/serum …
carcinogenesis and cancer development, and that it is stably detectable in plasma/serum …
MicroRNA in pancreatic cancer: from biology to therapeutic potential
Pancreatic cancer is one of the most aggressive malignancies, accounting for more than
45,750 deaths annually in the US alone. The aggressive nature and late diagnosis of …
45,750 deaths annually in the US alone. The aggressive nature and late diagnosis of …
The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer
C Labbaye, U Testa - Journal of hematology & oncology, 2012 - Springer
MicroRNA (miRs) represent a class of small non-coding regulatory RNAs playing a major
role in the control of gene expression by repressing protein synthesis at the post …
role in the control of gene expression by repressing protein synthesis at the post …
The microRNA-183 cluster: the family that plays together stays together
S Dambal, M Shah, B Mihelich, L Nonn - Nucleic acids research, 2015 - academic.oup.com
Abstract The microRNA (miR) 183 cluster, which is comprised of miRs-183,-96 and-182, is
also a miR family with sequence homology. Despite the strong similarity in the sequences of …
also a miR family with sequence homology. Despite the strong similarity in the sequences of …